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Abstract
Background and purpose—Patients with stroke can experience neurological deterioration in 
the prehospital setting. We evaluated patients with stroke to determine factors associated with 
prehospital neurological deterioration (PND).
Methods—Among the Greater Cincinnati/Northern Kentucky region (population ~1.3 million), 
we screenedall 15 local hospitals’ admissions from 2010 for acute stroke and included patients 
aged ≥20. The GCS was compared between emergency medical services (EMS) arrival and 
hospital arrival, with decrease ≥2 points considered PND. Data obtained retrospectively included 
demographics, medical history and medication use, stroke subtype (eg, ischaemic stroke (IS), 
intracerebral haemorrhage (ICH), subarachnoid haemorrhage(SAH)) and IS subtype (eg, small 
vessel, large vessel, cardioembolic), seizure at onset, time intervals between symptom onset, EMS 
arrival and hospital arrival, EMS level of training, and blood pressure and serum glucose on EMS 
arrival.
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Results—Of 2708 total patients who had a stroke, 1092 patients (median (IQR) age 74 (61–83) 
years;56% women; 21% black) were analysed. PND occurredin 129 cases (12%), including 9% of 
IS, 24% of ICHand 16% of SAH. In multivariable analysis, black race, atrial fibrillation, 
haemorrhagic subtype and ALS level of transport were associated with PND.
Conclusion—Haemorrhage and atrial fibrillation is associated with PND in stroke, and further 
investigationis needed to establish whether PND can be predicted. Further studies are also needed 
to assess whether preferential transport of patients with deterioration to hospitals equipped with 
higher levels of care is beneficial, identify why race is associated with deterioration and to test 
therapies targeting PND.
INTRODUCTION
Neurological deterioration, which may occur soon after the onset of stroke, has been 
associated with worse outcomes.12 Previous studies have shown early deterioration in the 
presence of intracerebral haemorrhage,3–5 but the frequency and importance of acute 
worsening in ischaemic stroke and subarachnoid haemorrhage is unclear. There have been 
no large, population-based studies to evaluate prehospital neurological deterioration (PND) 
in both ischaemic and haemorrhagic cases of stroke. While current prehospital stroke 
severity scales have shown potential benefit in triage,67 these do not include clinical change 
in their assessments. Acute deterioration may be another useful marker for patients requiring 
comprehensive stroke centres or other higher levels of care.
We evaluated patients with ischaemic stroke, intracerebral haemorrhage and subarachnoid 
haemorrhage to determine the frequency of PND in patients with acute haemorrhagic and 
ischaemic stroke presenting to regional Emergency Departments via emergency medical 
services (EMS), and we explore the association of PND with demographic and clinical 
variables.
METHODS
Greater Cincinnati/Northern Kentucky Strokestudy
The methods of the Greater Cincinnati/Northern Kentucky Stroke Study (GCNKSS) have 
been previously described.89 Briefly, the National Institutes of Health (NIH)–funded 
GCNKSS systematically ascertained the population-based stroke incidence in calendar year 
2010 from a 5-county, 15-hospital region with a population of about 1.3 million. During 
2010, there was no specified triage of patients with stroke, and EMS was advised to 
transport to the nearest appropriate hospital. The medical records of all patients in the region 
with a hospital diagnosis of stroke or transient ischaemic attack using discharge International 
Classification of Diseases, Ninth Revision codes of 430–436 are screened by research 
nurses, with further adjudication by study physicians to an epistry. The epistry contains 
detailed sociodemographic and clinical data, including medical history, medication use, 
imaging/laboratory results and outcomes, inclusive of the prehospital, ED and inpatient 
phases of care. The GCNKSS was approved by the institutional review board (IRB) or 
equivalent at all 15 hospitals. Written informed consent was waived by the IRB.
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Subject selection
The present analysis included patients with acute ischaemic stroke (IS), intracranial 
haemorrhage (ICH) or subarachnoid haemorrhage (SAH) who were at least 20 years of age, 
presented to an ED via EMS, and had GCS data from both EMS and ED records.
Primary outcome
PND was defined as a decrease in GCS score of at least two points between the initial EMS 
and ED evaluations, as has been defined in previous literature.10
Variables of interest
Variables were chosen for analysis based on previous reports that identified possible factors 
that influence early neurological change.34 Demographic and clinical variables included age, 
sex, race (black, white, other), medical history (hypertension, diabetes, atrial fibrillation and 
prior stroke), previous antiplatelet or anticoagulation use, stroke type (IS, ICH or SAH) and 
IS subtype (small vessel, large vessel, cardioembolic, other known cause, cryptogenic), 
seizure at onset, time from symptom onset to EMS arrival, time from EMS to ED arrival, 
EMS level of training as ALS or basic life support, and initial blood pressure and serum 
glucose on EMS arrival.
In cases where the onset of symptoms was not witnessed, the time last seen normal was used 
to calculate the elapsed time from symptom onset to EMS arrival. In cases where EMS 
arrival time was not documented, time of the first set of vital signs documented by EMS was 
used to estimate EMS arrival time. Seizure at onset was derived from patient-reported 
symptoms that led to calling EMS.
Statistical analysis
Demographic and clinical variables were compared between cohorts with and without PND 
using χ2 tests for categorical data and Wilcoxon rank-sum tests for continuous variables. 
Age, glucose on EMS arrival and blood pressure on EMS arrival were treated as continuous 
variables. Elapsed time between onset and EMS arrival was treated as a categorical variable 
(in hours) as 0–4.5, 4.5–24 and ‘>24 or unknown’. Time was categorised as such due to the 
significance of the cut-offs of 4.5 hours after symptom onset and 24 hours after symptom 
onset in acute stroke medical and endovascular treatment, respectively.
Multivariable logistic regression was used to identify potential risk factors with PND as the 
dependent variable and potential risk factors determined by those variables with p values 
≤0.20 in the univariate analysis. In regards to race, ‘white’ and ‘other’ groups were 
combined due to the lack of a significant percentage in the ‘other’ category in our 
population. OR with 95% CIs and p values were reported, with p values less than 0.05 
considered statistically significant. SAS V9.4 (SAS Institute, Cary, North Carolina, USA) 
was used for all data analyses.
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RESULTS
Among 2708 patients ≥20 years of age who had an IS, ICH or SAH event in 2010, 1092 
used EMS, presented to an ED, and had GCS data for both EMS and the ED. These subjects 
had a median age of 74 years (IQR 61–83), 55% were women and 21% were black. 
Ischaemic stroke was diagnosed in 866, 175 had an ICH and 51 had a SAH. Time from 
witnessed onset or last known well to EMS arrival was ≤4.5 hours for 504 (46%), and 
median time from EMS arrival on-scene to ED arrival was 26 min. PND between EMS and 
ED occurred in 129 cases overall (12%), including 9% of IS, 24% of ICH and 16% of SAH 
cases. Figure 1 depicts the distribution of changes in GCS.
Factors associated with PND in the univariate analysis are listed in table 1, showing that 
female gender, history of atrial fibrillation, previous use of antiplatelet medication, 
haemorrhagic and subarachnoid stroke subtype, cardioembolic subtype of ischaemic stroke, 
lower baseline and hospital GCS score, ALS level of transport and reported symptom of 
seizure were all significantly associated with PND. Multivariable analysis completed on all 
variables with p values ≤0.20 in the univariate analysis found that black race, atrial 
fibrillation, haemorrhagic subtype of stroke and ALS transport were independently 
associated with PND (table 2).
In univariate analysis of IS cases, age, female sex, medical history of atrial fibrillation, 
cardioembolic subtype, higher initial EMS GCS score and reported symptom of seizure were 
associated with PND. In multivariable analysis of IS cases, female sex (OR 1.93, p = 0.01), 
black race (OR 1.84, p = 0.03) and stroke subtype (cardioembolic vs cryptogenic (OR 1.73) 
and cardioem- bolic vs large vessel/small vessel/other (OR 3.38), p<0.01) were significant 
predictors of PND.
In the ICH subgroup, only EMS glucose on arrival was significantly associated with PND in 
the univariate analysis, which remained significant in the multivariable model (OR 0.99, p = 
0.03). SAH subgroup analysis was not performed because data were limited due to small 
number of events (51 cases and eight deterioration events).
DISCUSSION
In this analysis of a large population-based study of patients with stroke, we found that PND 
occurs in 12% of subjects overall, is more common with black race and in patients with 
intracranial haemorrhage, and is associated with atrial fibrillation and cardioembolic 
ischaemic strokes. Our study was based out of a metropolitan area, and it is possible that 
there may be even more significant proportions of PND in rural areas due to longer times of 
transport. To our knowledge, this is the first population-based estimate of PND in patients 
with stroke transported by EMS. Our study provides evidence that deterioration may be used 
in initial triage and management of patients in the prehospital setting. Future studies also 
need to be conducted to assess whether therapies to target PND are beneficial.
Guidelines have already established preferential triage of patients with suspected stroke to 
primary or comprehensive stroke centres,11 and there has been some evidence supporting 
more specified levels of triage to endovascular capable centres or comprehensive stroke 
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centres based on clinical scales for large vessel occlusion.67 The significant association of 
haemor- rhagic stroke with PND may help providers by guiding hospital prenotification and 
justify preferential triage of patients with acute worsening to centres capable of managing 
haemorrhagic stroke with on-call neurosurgical services. Also, there is evidence that large-
vessel occlusions related to cardioembolic aetiology may lead to a longer time during the 
mechanical thrombectomy procedure until recanalisation is achieved,12 which may support 
triage of patients with atrial fibrillation to an endovascular capable centre initially in the 
prehospital setting, based on the association between PND and atrial fibrillation. 
Furthermore, the occurrence of PND in a significant amount of patients with stroke supports 
including deterioration in the formulation of future prehospital clinical scales that are used in 
triage, which all currently only include a single assessment.6
Previous studies on PND in stroke have involved only patients with ICH, and these showed 
higher proportions of deterioration than our study.34 Haemorrhagic stroke has previously 
been described to lead to more cases of early neurological deterioration than ischaemic 
stroke, with 22% of haemorrhage cases experiencing deterioration versus 7% of ischaemic 
cases in one study,1 which are similar rates as our results. Our study likely had a lower 
proportion of deterioration also because its population-based design does not have the 
severity bias common in single-centre cohorts. Including all subtypes of stroke in the 
analysis is appropriate, given that EMS is unable to differentiate between subtypes of stroke 
with certainty in the prehospital setting.
In contrast to the previous studies on PND in patients with ICH,3–5 EMS blood pressure, 
prior antiplatelet use and time of transport were not significantly associated with PND in our 
study, even with stratified analysis on patients with IS and ICH separately. A previous study 
of patients with acute stroke treated with intravenous tissue plasminogen activator found that 
early neurological deterioration was significantly associated with atrial fibrillation.13 In our 
study, atrial fibrillation was significantly associated with PND and cardioembolic subtype 
was significantly associated with PND in IS cases in the multivariable analysis.
We found that black race was an independent predictor of PND. One other single-centre 
study in patients with ICH included race as a covariate but did not find race to be associated 
with deterioration.3 Further studies are needed to evaluate how race is linked to PND. We 
also found that ALS transport was associated with PND. This finding could reflect 
appropriate initial triage of patients by the EMS dispatcher and by EMS providers in the 
field, as patients who were identified as having more severe conditions or those deemed 
likely of undergoing rapid change in status would be transported preferentially by providers 
with a higher level of training. It is unclear why more acute stroke cases were not more 
likely to have further deterioration, reflected by the lack of significant association between 
PND and time interval of LKN to EMS arrival, even when haem- orrhagic stroke cases were 
analysed separately. However, the subgroup analysis on haemorrhagic cases does show a 
non-significant trend with more cases exhibiting PND in the 0–4.5 hour subgroup (52% of 
all ICH cases with PND) than the 4.5–24 hour subgroup (29% of all ICH cases with PND) 
or the greater than 24 hours subgroup (19% of all ICH cases with PND). It remains possible 
that the number of haemorrhagic cases was too few to show a significant association.
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A limitation of this study is the use of ‘decrease in GCS between EMS and ED arrival’ as a 
surrogate for deterioration of neurological function while en route, which has been shown to 
have only moderate inter-rater reliability.14 In the absence of widespread standardised use of 
other measures of neurological function in EMS setting, GCS is the best measure of 
neurological status and has been used previously in stroke.10 GCS score has also been 
shown to be associated with outcome in stroke.1516 Variability in full NIH stroke scale 
would be a better determinant of prehospital clinical changes for a smaller prospective study, 
but the full scale is not performed uniformly by EMS, if at all. Also, possibly due to our 
urban setting, there was lack of large variances in transport times in our population, and 
EMS arrival to ED arrival time was not found to be significantly associated with PND. There 
are further limitations inherent to a retrospective study, such as limitation to what is 
documented in chart review, errors with classification of stroke subtype or IS subtype, and 
errors with the estimation methods used for EMS arrival.
CONCLUSION
PND is not uncommon in patients with stroke transported by EMS, and deterioration is 
associated with race, intracranial haemorrhage and cardioembolic subtype of ischaemic 
strokes. Further studies are needed to assess whether the occurrence of deterioration can 
help aid in triage or intervention in the prehospital setting. The additive value of PND to 
existing prehospital stroke triage criteria also requires further evaluation.
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Key messages
What is already known on the subject
• Early neurological deterioration has been associated with worse outcomes.
• In cases of intracerebral haemorrhage, deterioration can occur in the 
prehospital and early hospital settings.
• There have been no large, population-based studies to evaluate prehospital 
neurological deterioration and its association with predictive factors in all 
cases of stroke.
What this study adds
• In a large population sample, the occurrence of prehospital neurological 
deterioration is independently associated with race, haemorrhagic type of 
stroke and cardioembolic subtype of ischaemic stroke.
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Figure 1. 
Distribution of changes in GCS score between EMS assessment and ED assessment in all 
analysed patients.
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Table 1
Univariate analysis of factors associated with PND, n=1092
PND (n=129) No PND (n=963) P values
Age, median (IQR) 76 (63–85) 73 (60–83) 0.18
Female gender 82 (64%) 524 (54%) 0.049
Race 0.07
 White 91 (71%) 763 (79%)
 Black 37 (29%) 191 (20%)
 Other 1 (1%) 9 (1%)
Medical history
 Hypertension 110 (85%) 783 (81 %) 0.27
 Diabetes 36 (28%) 311 (32%) 0.31
 Atrial fibrillation 49 (38%) 233 (24%) <0.01
 Previous stroke 28 (22%) 253 (26%) 0.27
Medication prior to onset
 Antiplatelet 50 (39%) 462 (48%) 0.049
 Anticoagulation 22(17%) 125 (13%) 0.20
Stroke type <0.01
 Ischaemic 79(61%) 787 (82%)
 Haemorrhagic 42 (33%) 133 (14%)
 Subarachnoid 8 (6%) 43 (4%)
Ischaemic stroke subtype n=79 n=787 <0.01
 Large vessel 7 (9%) 114 (14%)
 Cardioembolic 44 (56%) 264 (34%)
 Small vessel 1 (1%) 100 (13%)
 Cryptogenic—undetermined aetiology 25 (32%) 276 (35%)
 Other 2 (3%) 33 (4%)
LKN to EMS arrival at scene 0.31
 0–4.5 hours 66 (51%) 438 (45%)
 4.5–24hours 42 (33%) 317 (33%)
 >24 hours 21 (16%) 208 (22%)
EMS arrival to hospital in minutes, median (IQR) n=127 26 (21–33) n=907 26 (20–34) 0.99
GCS EMS, median (IQR) 13 (11–15) 15 (12–15) <0.01
GCS hospital, median (IQR) 10 (6–11) 15 (13–15) <0.01
Glucose EMS in mg/dL, median (IQR) n=96 130 (106–151) n=631 134 (109–171) 0.26
BP EMS, mm Hg
 Systolic, median (IQR) n=122 157 (138,180) n=923 150 (132,177) 0.44
 Diastolic, median (IQR) n=121 80 (62–100) n=919 82 (68–98) 0.95
EMS level of transport 0.04
 ALS 105 (83%) 698 (74%)
 BLS 22 (17%) 240 (26%)
Symptom of seizure 11 (9%) 42 (4%) 0.04
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BLS, basic life support; EMS, emergency medical services; LKN, last known normal; PND, prehospital neurological deterioration.
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Table 2
Multivariable logistic regression of predictors of prehospital neurological deterioration for variables with p 
values ≤0.20 in univariate analysis
OR(95%CI) P values
Age 1.01 (0.99 to 1.02) 0.33
Female gender 1.37 (0.92 to 2.05) 0.12
Race
 White/other Reference
 Black 2.32 (1.42 to 3.77) <0.01
Medical history
 Atrial fibrillation 2.52 (1.54 to 4.11) <0.01
Medication prior to onset
 Antiplatelet 0.71 (0.47 to 1.06) 0.09
 Anticoagulation 0.86 (0.48 to 1.54) 0.61
Stroke type
 Ischaemic Reference
 Haemorrhagic/subarachnoid 3.14 (2.03 to 4.86) <0.01
GCS EMS 1.02 (0.96 to 1.08) 0.47
EMS level of training
 BLS Reference
 ALS 1.84 (1.06 to 3.18) 0.03
Symptom of seizure 1.35 (0.64 to 2.85) 0.43
BLS, basic life support: EMS, emergency medical services.
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